Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Haskalife(TM) Canadian Haskap Berry Powder Formulation on Hypertension and Acuity in Women's Health

NCT06764121 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.

NCT NCT06764121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06764121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Haskalife(TM) Canadian Haskap Berry Powder Formulation on Hypertension and Acuity in Women's Health
Lead sponsor
University of Manitoba
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 3, 2025
Completion date
August 6, 2026
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alertness, hypertension